_version_ 1784823836327280640
author Iacoboni, Gloria
Rejeski, Kai
Villacampa, Guillermo
van Doesum, Jaap A.
Chiappella, Annalisa
Bonifazi, Francesca
Lopez-Corral, Lucia
van Aalderen, Michiel
Kwon, Mi
Martínez-Cibrian, Nuria
Bramanti, Stefania
Reguera-Ortega, Juan Luis
Camacho-Arteaga, Lina
Schmidt, Christian
Marín-Niebla, Ana
Kersten, Marie José
Martin Garcia-Sancho, Alejandro
Zinzani, Pier Luigi
Corradini, Paolo
van Meerten, Tom
Subklewe, Marion
Barba, Pere
author_facet Iacoboni, Gloria
Rejeski, Kai
Villacampa, Guillermo
van Doesum, Jaap A.
Chiappella, Annalisa
Bonifazi, Francesca
Lopez-Corral, Lucia
van Aalderen, Michiel
Kwon, Mi
Martínez-Cibrian, Nuria
Bramanti, Stefania
Reguera-Ortega, Juan Luis
Camacho-Arteaga, Lina
Schmidt, Christian
Marín-Niebla, Ana
Kersten, Marie José
Martin Garcia-Sancho, Alejandro
Zinzani, Pier Luigi
Corradini, Paolo
van Meerten, Tom
Subklewe, Marion
Barba, Pere
author_sort Iacoboni, Gloria
collection PubMed
description
format Online
Article
Text
id pubmed-9631549
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Society of Hematology
record_format MEDLINE/PubMed
spelling pubmed-96315492022-11-04 Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma Iacoboni, Gloria Rejeski, Kai Villacampa, Guillermo van Doesum, Jaap A. Chiappella, Annalisa Bonifazi, Francesca Lopez-Corral, Lucia van Aalderen, Michiel Kwon, Mi Martínez-Cibrian, Nuria Bramanti, Stefania Reguera-Ortega, Juan Luis Camacho-Arteaga, Lina Schmidt, Christian Marín-Niebla, Ana Kersten, Marie José Martin Garcia-Sancho, Alejandro Zinzani, Pier Luigi Corradini, Paolo van Meerten, Tom Subklewe, Marion Barba, Pere Blood Adv Research Letter American Society of Hematology 2022-06-20 /pmc/articles/PMC9631549/ /pubmed/35271707 http://dx.doi.org/10.1182/bloodadvances.2021006922 Text en © 2022 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.
spellingShingle Research Letter
Iacoboni, Gloria
Rejeski, Kai
Villacampa, Guillermo
van Doesum, Jaap A.
Chiappella, Annalisa
Bonifazi, Francesca
Lopez-Corral, Lucia
van Aalderen, Michiel
Kwon, Mi
Martínez-Cibrian, Nuria
Bramanti, Stefania
Reguera-Ortega, Juan Luis
Camacho-Arteaga, Lina
Schmidt, Christian
Marín-Niebla, Ana
Kersten, Marie José
Martin Garcia-Sancho, Alejandro
Zinzani, Pier Luigi
Corradini, Paolo
van Meerten, Tom
Subklewe, Marion
Barba, Pere
Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma
title Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma
title_full Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma
title_fullStr Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma
title_full_unstemmed Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma
title_short Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma
title_sort real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631549/
https://www.ncbi.nlm.nih.gov/pubmed/35271707
http://dx.doi.org/10.1182/bloodadvances.2021006922
work_keys_str_mv AT iacobonigloria realworldevidenceofbrexucabtageneautoleucelforthetreatmentofrelapsedorrefractorymantlecelllymphoma
AT rejeskikai realworldevidenceofbrexucabtageneautoleucelforthetreatmentofrelapsedorrefractorymantlecelllymphoma
AT villacampaguillermo realworldevidenceofbrexucabtageneautoleucelforthetreatmentofrelapsedorrefractorymantlecelllymphoma
AT vandoesumjaapa realworldevidenceofbrexucabtageneautoleucelforthetreatmentofrelapsedorrefractorymantlecelllymphoma
AT chiappellaannalisa realworldevidenceofbrexucabtageneautoleucelforthetreatmentofrelapsedorrefractorymantlecelllymphoma
AT bonifazifrancesca realworldevidenceofbrexucabtageneautoleucelforthetreatmentofrelapsedorrefractorymantlecelllymphoma
AT lopezcorrallucia realworldevidenceofbrexucabtageneautoleucelforthetreatmentofrelapsedorrefractorymantlecelllymphoma
AT vanaalderenmichiel realworldevidenceofbrexucabtageneautoleucelforthetreatmentofrelapsedorrefractorymantlecelllymphoma
AT kwonmi realworldevidenceofbrexucabtageneautoleucelforthetreatmentofrelapsedorrefractorymantlecelllymphoma
AT martinezcibriannuria realworldevidenceofbrexucabtageneautoleucelforthetreatmentofrelapsedorrefractorymantlecelllymphoma
AT bramantistefania realworldevidenceofbrexucabtageneautoleucelforthetreatmentofrelapsedorrefractorymantlecelllymphoma
AT regueraortegajuanluis realworldevidenceofbrexucabtageneautoleucelforthetreatmentofrelapsedorrefractorymantlecelllymphoma
AT camachoarteagalina realworldevidenceofbrexucabtageneautoleucelforthetreatmentofrelapsedorrefractorymantlecelllymphoma
AT schmidtchristian realworldevidenceofbrexucabtageneautoleucelforthetreatmentofrelapsedorrefractorymantlecelllymphoma
AT marinnieblaana realworldevidenceofbrexucabtageneautoleucelforthetreatmentofrelapsedorrefractorymantlecelllymphoma
AT kerstenmariejose realworldevidenceofbrexucabtageneautoleucelforthetreatmentofrelapsedorrefractorymantlecelllymphoma
AT martingarciasanchoalejandro realworldevidenceofbrexucabtageneautoleucelforthetreatmentofrelapsedorrefractorymantlecelllymphoma
AT zinzanipierluigi realworldevidenceofbrexucabtageneautoleucelforthetreatmentofrelapsedorrefractorymantlecelllymphoma
AT corradinipaolo realworldevidenceofbrexucabtageneautoleucelforthetreatmentofrelapsedorrefractorymantlecelllymphoma
AT vanmeertentom realworldevidenceofbrexucabtageneautoleucelforthetreatmentofrelapsedorrefractorymantlecelllymphoma
AT subklewemarion realworldevidenceofbrexucabtageneautoleucelforthetreatmentofrelapsedorrefractorymantlecelllymphoma
AT barbapere realworldevidenceofbrexucabtageneautoleucelforthetreatmentofrelapsedorrefractorymantlecelllymphoma